These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31377474)

  • 1. Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction.
    Banerjee A; Dash SP; Mohanty M; Sanna D; Sciortino G; Ugone V; Garribba E; Reuter H; Kaminsky W; Dinda R
    J Inorg Biochem; 2019 Oct; 199():110786. PubMed ID: 31377474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of DNA/BSA interaction and catalytic potential of oxidovanadium(v) complexes with ONO donor ligands.
    Dash SP; Panda AK; Dhaka S; Pasayat S; Biswas A; Maurya MR; Majhi PK; Crochet A; Dinda R
    Dalton Trans; 2016 Nov; 45(45):18292-18307. PubMed ID: 27805190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity.
    Lima S; Banerjee A; Sahu G; Patra SA; Sahu K; Sasamori T; Sciortino G; Garribba E; Dinda R
    J Inorg Biochem; 2022 Aug; 233():111853. PubMed ID: 35598422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mononuclear and dinuclear monoperoxovanadium(v) complexes with a hetero ligand. 1.(1) Self-decomposition reaction, detection of reactive oxygen species, and oxidizing ability.
    Kanamori K; Nishida K; Miyata N; Shimoyama T; Hata K; Mihara C; Okamoto K; Abe Y; Hayakawa S; Matsugo S
    Inorg Chem; 2004 Nov; 43(22):7127-40. PubMed ID: 15500351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
    Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
    Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New V
    Banerjee A; Dash SP; Mohanty M; Sahu G; Sciortino G; Garribba E; Carvalho MFNN; Marques F; Costa Pessoa J; Kaminsky W; Brzezinski K; Dinda R
    Inorg Chem; 2020 Oct; 59(19):14042-14057. PubMed ID: 32914971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dithiocarbazate based oxidomethoxidovanadium(V) and mixed-ligand oxidovanadium(IV) complexes: Study of solution behavior, DNA binding, and anticancer activity.
    Sahu G; Patra SA; Mohanty M; Lima S; Pattanayak PD; Kaminsky W; Dinda R
    J Inorg Biochem; 2022 Aug; 233():111844. PubMed ID: 35512606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
    Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
    J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding.
    Gonçalves G; Tomaz I; Correia I; Veiros LF; Castro MM; Avecilla F; Palacio L; Maestro M; Kiss T; Jakusch T; Garcia MH; Pessoa JC
    Dalton Trans; 2013 Sep; 42(33):11841-61. PubMed ID: 23677414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses, crystal structures, DFT calculations, protein interaction and anticancer activities of water soluble dipicolinic acid-imidazole based oxidovanadium(iv) complexes.
    Biswal D; Pramanik NR; Chakrabarti S; Drew MGB; Acharya K; Chandra S
    Dalton Trans; 2017 Dec; 46(47):16682-16702. PubMed ID: 29168865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: Exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex.
    Patra SA; Mohanty M; Banerjee A; Kesarwani S; Henkel F; Reuter H; Dinda R
    J Inorg Biochem; 2021 Nov; 224():111582. PubMed ID: 34450411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadium complexes having [VO]2+, [VO]3+ and [VO2]+ cores with hydrazones of 2,6-diformyl-4-methylphenol: synthesis, characterization, reactivity, and catalytic potential.
    Maurya MR; Haldar C; Kumar A; Kuznetsov ML; Avecilla F; Costa Pessoa J
    Dalton Trans; 2013 Sep; 42(33):11941-62. PubMed ID: 23680862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities.
    Yuan C; Lu L; Gao X; Wu Y; Guo M; Li Y; Fu X; Zhu M
    J Biol Inorg Chem; 2009 Aug; 14(6):841-51. PubMed ID: 19290551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of V(IV)O complexes of picolinate and pyrazine derivatives. Behavior in the solid state and aqueous solution and biotransformation in the presence of blood plasma proteins.
    Koleša-Dobravc T; Lodyga-Chruscinska E; Symonowicz M; Sanna D; Meden A; Perdih F; Garribba E
    Inorg Chem; 2014 Aug; 53(15):7960-76. PubMed ID: 25013935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Primary Ligands (ODA, TDA) on Physicochemical and Biological Properties of Oxidovanadium (IV) Complexes with Bipy and Phen as Auxiliary Ligands.
    Pranczk J; Tesmar A; Wyrzykowski D; Inkielewicz-Stępniak I; Jacewicz D; Chmurzyński L
    Biol Trace Elem Res; 2016 Nov; 174(1):251-258. PubMed ID: 27048276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photo-induced double-strand DNA and site-specific protein cleavage activity of L-histidine (mu-oxo)diiron(III) complexes of heterocyclic bases.
    Roy M; Bhowmick T; Santhanagopal R; Ramakumar S; Chakravarty AR
    Dalton Trans; 2009 Jun; (24):4671-82. PubMed ID: 19513475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the cell cytotoxicity and DNA/BSA binding and cleavage activity of some dioxidovanadium(V) complexes containing aroylhydrazones.
    Dash SP; Panda AK; Pasayat S; Majumder S; Biswas A; Kaminsky W; Mukhopadhyay S; Bhutia SK; Dinda R
    J Inorg Biochem; 2015 Mar; 144():1-12. PubMed ID: 25575303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
    Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
    J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations.
    Sciortino G; Sanna D; Ugone V; Micera G; Lledós A; Maréchal JD; Garribba E
    Inorg Chem; 2017 Nov; 56(21):12938-12951. PubMed ID: 28985059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity.
    Sasmal PK; Saha S; Majumdar R; Dighe RR; Chakravarty AR
    Inorg Chem; 2010 Feb; 49(3):849-59. PubMed ID: 20039725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.